Scientific founders of seed companies often do not have the expertise, capabilities, and/or time for all the critical aspects in turning science into a business. Their primary focus, as leading experts, should be on their key strength – advancing science.

However, the harsh reality of today’s economic environment is that science alone is not enough for funding. Venture firms need to see science aligned with a commercially viable strategic vision and the operational capacity to execute.

Ex³ helps startups that are struggling with operational decisions – from hiring C-suite executives, to figuring out a company’s IT and administrative needs, Ex³ accelerates companies from Seed funding to the next round of funding through IPO.

At Ex³, we understand the unique challenges faced by early-stage biotech companies. We have worked with numerous startups, witnessing journeys from conception to commercialization. Our extensive knowledge and hands-on approach offer solutions tailored to your needs, ensuring success at every step of the way.

Please reach out to karol.sokolowski@portalinnovations.com.